Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day

DuPont is now marketing Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day.

Sustiva is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...in the same class as Rescriptor and Viramune.

It seems to be as potent as a protease inhibitor...when combined with the nucleoside inhibitors Retrovir and Epivir.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote